Exhibit 99.2
WEBMD HEALTH CORP.
PRELIMINARY FINANCIAL INFORMATION
(in millions, except per share amounts)
(unaudited)
Quarter Ended June 30, 2017 (Preliminary) | ||||
Revenue | $ | 176.0 | ||
|
| |||
Net income | $ | 18.9 | ||
|
| |||
Interest, taxes,non-cash and other items (a) | ||||
Interest income | (1.9 | ) | ||
Interest expense | 7.0 | |||
Income tax provision | 11.9 | |||
Depreciation and amortization | 7.6 | |||
Non-cash stock-based compensation | 8.9 | |||
Transaction expense | 2.1 | |||
Other income | (0.6 | ) | ||
|
| |||
Earnings before interest, taxes,non-cash and other items (“Adjusted EBITDA”) (b) | $ | 53.9 | ||
|
| |||
Net income per common share: | ||||
Basic | $ | 0.51 | ||
|
| |||
Diluted | $ | 0.43 | ||
|
| |||
Weighted-average shares outstanding used in computing income per common share: | ||||
Basic | 37.1 | |||
|
| |||
Diluted | 54.4 | |||
|
|
(a) | Reconciliation of net income to Adjusted EBITDA. |
(b) | See AnnexA-Explanation ofNon-GAAP Financial Measures. |
Additional information regarding preliminary results for the quarter ended June 30, 2017:
• | Transaction expense represents professional fees incurred in connection with the |
process conducted by the Board of Directors to explore strategic alternatives
for the Company.
• | Other income represents a gain on the sale of property. |